Suchergebnisse
Filter
9 Ergebnisse
Sortierung:
SSRN
Severe acute respiratory syndrome coronavirus-2-associated perceived stress and anxiety among indian medical students: A cross-sectional study
In: Asian journal of social health and behavior, Band 4, Heft 3, S. 98
ISSN: 2772-4204
SSRN
Working paper
Removal of organic dyes from wastewater using Eichhornia crassipes: a potential phytoremediation option
In: Environmental science and pollution research: ESPR, Band 28, Heft 6, S. 7116-7122
ISSN: 1614-7499
Prevalence of Polypharmacy, Hyperpolypharmacy and Potentially Inappropriate Medication Use in Older Adults in India: A Systematic Review and Meta-Analysis
Background: Older people often receive multiple medications for chronic conditions, which often result in polypharmacy (concomitant use of 5‒9 medicines) and hyperpolypharmacy (concomitant use of ≥10 medicines). A limited number of studies have been performed to evaluate the prevalence of polypharmacy, hyperpolypharmacy, and potentially inappropriate medication (PIM) use in older people of developing countries. The present study aimed to investigate regional variations in the prevalence of polypharmacy, hyperpolypharmacy, and PIM use in older people (60 + years) in India. Methods: Studies were identified using Medline/PubMed, Scopus, and Google Scholar databases published from inception (2002) to September 31, 2020. Out of the total 1890 articles, 27 were included in the study. Results: Overall, the pooled prevalence of polypharmacy was 49% (95% confidence interval: 42–56; p < 0.01), hyperpolypharmacy was 31% (21–40; p < 0.01), and PIM use was 28% (24–32; p < 0.01) among older Indian adults. Polypharmacy was more prevalent in North-east India (65%, 50–79), whereas hyperpolypharmacy was prevalent in south India (33%, 17–48). Region-wize estimates for the pooled prevalence of PIM use in India were as follows: 23% (21–25) in East, 33% in West (24–42), 17.8% in North (11–23), and 32% (26–38) in South India. The prevalence of PIM use in adults aged ≥70°years was 35% (28–42), in those taking more medications (≥5.5/day) was 27% (22–31), and in adults using a high number of PIMs (≥3) was 29% (22–36). Subgroup analysis showed that cross-sectional studies had a higher pooled prevalence of polypharmacy 55% (44–65) than cohorts 45% (37–54). Hyperpolypharmacy in inpatient care settings was 37% (26–47), whereas PIM use was higher in private hospitals 31% (24–38) than government hospitals 25% (19–31). Conclusion: Polypharmacy and hyperpolypharmacy are widely prevalent in India. About 28% of older Indian adults are affected by PIM use. Thus, appropriate steps are needed to promote rational geriatric prescribing in ...
BASE
Architecting the Z-scheme heterojunction of Gd2O3/g-C3N4 nanocomposites for enhanced visible-light-induced photoactivity towards organic pollutants degradation
In: Environmental science and pollution research: ESPR, Band 30, Heft 44, S. 98773-98786
ISSN: 1614-7499
Mg/Li@GCN as highly active visible light responding 2D photocatalyst for wastewater remediation application
In: Environmental science and pollution research: ESPR, Band 30, Heft 44, S. 98540-98547
ISSN: 1614-7499
ESG Investments for Sustainability with Superior Returns in Indian Equity Market
In: Tiwari, R., Chauhan, A. S., Agrawal, P., Goel, S., Sharma, R., Chaudhary, V., Kumari, K. and Kumari, S., (2022). ESG Investments for Sustainability with Superior Returns in Indian Equity Market. YMER, Vol. 21, No 11, (2022), pp. 777-783
SSRN
Consequential Damages: Alien Vomit or Intelligent Design?
In: Washington University Law Review, Forthcoming
SSRN